Mycobacterium tuberculosis Beijing genotype emerging in vietnam

Emerging Infectious Diseases

Volumn 6, Issue 3, 2000, Pages 302-305

  Anh, Dang Duc ^a   Borgdorff, Martien W ^b   Van, L N ^c   Lan, N T N ^d   Van Gorkom, Tamara ^e   Kremer, Kristin ^e   Van Soolingen, Dick ^e  

^a NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^b KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^c Natl Inst of TB/Resp Diseases   (Viet Nam)

^d TB and Lung Diseases Center   (Viet Nam)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; STREPTOMYCIN;

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BCG VACCINATION; CHINA; DISEASE TRANSMISSION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; STRAIN DIFFERENCE; TUBERCULOSIS; VIET NAM;

EID: 0034082491     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0603.000312     Document Type: Article

References (12)

1. Van Soolingen D, Borgdorff MW, de Haas PEW, Kremer K, Veen J, Sebek MGG, et al. Molecular epidemiology of tuberculosis in The Netherlands: a nationwide study during 1993 through 1997. J Infect Dis 1999;180:726-36.
2. Van Soolingen D, Qian L, de Haas PEW, Douglas JT, Traore H, Portaels F. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 1995;33:3234-8.
3. Van Loo IHM, van der Heide HGJ, Nagelkerke NJD, Mooi FR. Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J Infect Dis 1999;179:915-23.
4. Diaz R, Kremer K, de Haas PEW, Gomez RI, Marrero A, Valdivia JA. Molecular epidemiology of tuberculosis in Cuba outside of Havana, July 1994-June 1995: utility of spoligotyping versus IS6110 restriction fragment length polymorphism. Int J Tuberc Lung Dis 1998;2:743-50.
5. Niemann S, Rusch-Gergdes S, Richter E. IS6110 fingerprinting of drug-resistant Mycobacterium tuberculosis strains isolated in Germany during 1995. J Clin Microbiol 1997;35:3016-20.
6. Martilla HJ, Soini H, Eerola E, Vyshnevskaya E, Vyshnevskiy BI, Otten TF. A Ser315Thr substitution in katG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrobiol Agents Chemother 1998;42:2443-5.
7. Ghebremichael S, Kruuner A, Levina K, Kallenius G, Hoffner SE. Molecular epidemiology of multi-drug resistant (MDR) tuberculosis in Estonia. Abstracts of the 19th Annual Congress of the European Society of Mycobacteriology. 1998; IV: 334.
8. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996;275:452-7.
9. Netto EM, Dye C, Raviglione MC. Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Int J Tuberc Lung Dis 1999;3:310-20.
10. World Health Organization/International Union Against Tuberculosis and Lung Disease global project on anti-tuberculosis drug resistance surveillance, 1994-1997. Anti-tuberculosis drug resistance in the world. Geneva: The Organization; 1997.
11. Kamerbeek J, Schouls LM, Kolk A, Van Agterveld M, van Soolingen D, Kuijper S. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997;35:907-14.
12. Qian LS, Van-Embden JDA, Van der Zanden AGM, Weltevreden EF, Duanmu H, Douglas JT. Retrospective analysis of the Beijing family of Mycobacterium tuberculosis in preserved lung tissues. J Clin Microbiol 1999;37:471-4.